Hematology tests in Dubai & UAE

Compare available Hematology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

114

Listed price range

550.00–7,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hematology test prices

Showing 61–75 of 114 matching tests.

Hematology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2238 Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel (Customized Any 10 Markers) Test This diagnostic test evaluates the surface markers on blood or bone marrow cells to identify and classify leukemia.	Whole blood (EDTA + Sodium Heparin) or Bone Marrow aspirate	Same day (sample by 9 am)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukemia-associated cell surface markers", "Cell lineage and maturation stage"] Parameters [] Preparation ["Clinical history is mandatory", "No fasting required"] Indications ["Suspicion of leukemia", "Classification of leukemia subtypes", "Monitoring treatment response", "Evaluation of bone marrow failure"] Measurement technique Confirm with laboratory Codes LOINC: 94476-3 ICD-10: C95.00, C91.00, C92.00 Clinical summary This diagnostic test evaluates the surface markers on blood or bone marrow cells to identify and classify leukemia.
TEST-2242 Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel & Plasma Cell Dyscrasias Test This diagnostic test evaluates peripheral blood for abnormal hematopoietic cells using multiparametric flow cytometry to identify and classify leukemias and plasma cell dyscrasias.	Peripheral Whole Blood	Same-day reporting if sample received by 9 AM	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Abnormal hematopoietic cell populations", "Surface and cytoplasmic marker expression", "Lineage differentiation (B-cell, T-cell, Myeloid)", "Minimal Residual Disease (MRD)"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless otherwise directed by your physician", "Provide complete clinical history"] Indications ["Suspicion of leukemia (acute or chronic)", "Suspicion of plasma cell dyscrasias (e.g., multiple myeloma)", "Classification of hematologic malignancies", "Monitoring for minimal residual disease (MRD)", "Evaluation of unexplained cytopenias"] Measurement technique Confirm with laboratory Codes LOINC: 48508-3 ICD-10: C95.9, C91.0, C92.0, C90.0 Clinical summary This diagnostic test evaluates peripheral blood for abnormal hematopoietic cells using multiparametric flow cytometry to identify and classify leukemias and plasma cell dyscrasias.
TEST-2231 Immunophenotyping by Flow Cytometry: Leukemia/Lymphoma Diagnostic Panel Test This diagnostic test evaluates the surface markers on lymphocytes in blood or bone marrow to identify and classify chronic lymphoproliferative disorders.	Peripheral whole blood (3 mL each in EDTA and sodium heparin) or bone marrow aspirate (2 mL in sodium heparin)	Same-day (sample received by 9 AM)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Expression of specific CD markers on lymphocytes", "Lymphocyte subsets (T-cells and B-cells)"] Parameters [] Preparation ["Inform physician of all current medications (e.g., corticosteroids, immunosuppressants)", "Do not discontinue prescribed medications without consulting your doctor"] Indications ["Suspicion of leukemia or lymphoma", "Diagnosis and subtyping of chronic lymphoproliferative disorders", "Monitoring disease progression or response to treatment"] Measurement technique Confirm with laboratory Codes LOINC: 48508-3 ICD-10: C91.9 Clinical summary This diagnostic test evaluates the surface markers on lymphocytes in blood or bone marrow to identify and classify chronic lymphoproliferative disorders.
TEST-2261 Immunotyping Serum Test This test detects and characterizes monoclonal immunoglobulins (M-proteins) in serum.	Serum (Peripheral Blood)	Next Working Day	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Monoclonal immunoglobulins (M-proteins)", "Immunoglobulin type (IgG, IgA, etc.)", "Light chain restriction"] Parameters [] Preparation ["No special preparation required", "Maintain normal hydration", "Avoid vigorous shaking of the tube"] Indications ["Diagnosis of multiple myeloma", "Diagnosis of primary amyloidosis", "Diagnosis of MGUS", "Monitoring plasma cell disorders"] Measurement technique Confirm with laboratory Codes LOINC: 27020-1 ICD-10: C90.00, D47.2 Clinical summary This test detects and characterizes monoclonal immunoglobulins (M-proteins) in serum.
TEST-2280 Interleukin-6 (IL-6) PLUS Panel Test This diagnostic test evaluates systemic inflammation by measuring levels of interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP). It aids in risk stratification an...	Serum or plasma (peripheral blood)	Same day (sample received by 4 PM)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Interleukin-6 (IL-6)", "High-Sensitivity C-Reactive Protein (hs-CRP)", "Systemic inflammatory activation"] Parameters [{"name": "Interleukin-6 (IL-6)", "reference_range": null}, {"name": "High-Sensitivity C-Reactive Protein (hs-CRP)", "reference_range": null}] Preparation ["Overnight fasting preferred (water allowed)", "Avoid biotin supplements for 8 hours prior to collection"] Indications ["Suspected rheumatoid arthritis", "Cancer-related fatigue", "Post-COVID inflammatory syndrome", "Monitoring CAR-T therapy", "Early sepsis detection", "Cardiovascular risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 41117-5 ICD-10: R79.89 Clinical summary This diagnostic test evaluates systemic inflammation by measuring levels of interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP). It aids in risk stratification and monitoring of inflammatory conditions.
TEST-1978 JAK2 Somatic Mutation Analysis (Myelofibrosis) Test This test identifies somatic mutations in the JAK2 gene, which are key drivers in myelofibrosis and related blood disorders.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene somatic mutations", "V617F mutation", "Other JAK2 mutation hotspots"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected myelofibrosis", "Diagnosis of myeloproliferative neoplasms", "Guiding targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 42821-9 ICD-10: D47.1 Clinical summary This test identifies somatic mutations in the JAK2 gene, which are key drivers in myelofibrosis and related blood disorders.
TEST-1916 JAK2 V617F Mutation Analysis (Somatic) by NGS Test This test detects the somatic JAK2 V617F mutation in blood or DNA samples using Next-Generation Sequencing.	Whole blood (EDTA) or extracted DNA	14–21 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation", "Allele frequency"] Parameters [{"name": "JAK2 V617F Mutation Status", "reference_range": "Negative / Positive"}, {"name": "Allele Frequency (VAF)", "reference_range": "Reported as percentage (e.g., 1%, 5%, 10%...)"}] Preparation ["Avoid aspirin, NSAIDs, or herbal supplements for 48 hours before collection", "Inform the phlebotomist about all current medications"] Indications ["Diagnosis of polycythemia vera", "Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Monitoring minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 39380-3 ICD-10: D45, D47.3, D47.1 Clinical summary This test detects the somatic JAK2 V617F mutation in blood or DNA samples using Next-Generation Sequencing.
TEST-3268 KEL Gene (Kell Blood Group System) Hemolytic Anemia Genetic Test This test evaluates the KEL gene for variants associated with Kell blood group system-related haemolytic anaemia.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KEL gene variants", "Pathogenic mutations", "Polymorphisms", "Alleles"] Parameters [] Preparation ["Gather relevant medical records", "Provide family history", "Attend genetic counselling session"] Indications ["Diagnosis of Kell blood group system-related haemolytic anaemia", "Carrier screening", "Family planning", "Investigation of unexplained anaemia"] Measurement technique Confirm with laboratory Codes LOINC: 82319-5 ICD-10: D59.1, Z84.8 Clinical summary This test evaluates the KEL gene for variants associated with Kell blood group system-related haemolytic anaemia.
TEST-2208 Leukemia Diagnostic Comprehensive Profile (Flow Cytometry, 6 Markers) Test This test uses flow cytometry to identify and classify leukemia cells based on specific markers on their surface and inside them.	Bone Marrow Aspirate & Peripheral Blood	7 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cell surface antigens", "Cytoplasmic antigens", "Leukemic cell lineage"] Parameters [] Preparation ["No fasting required", "Inform doctor of blood thinners or chemotherapy schedules", "Inform lab of all current medications"] Indications ["Suspicion of leukemia", "Classification of leukemia subtypes", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 57962-9 ICD-10: C92.00, C91.00, C95.00, Z15.09 Clinical summary This test uses flow cytometry to identify and classify leukemia cells based on specific markers on their surface and inside them.
TEST-2452 Lupus Anticoagulant Panel (LAC Panel) Test This test evaluates for the presence of lupus anticoagulants, which are antiphospholipid antibodies associated with an increased risk of blood clots.	Whole Blood (Sodium Citrate Tube)	Next Day (Sample by 3 PM)	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Antiphospholipid antibodies", "Coagulation pathways (DRVVT, aPTT)"] Parameters [{"name": "DRVVT", "reference_range": null}, {"name": "aPTT-based assays", "reference_range": null}] Preparation ["Overnight fasting preferred", "Inform physician about all anticoagulant medications", "Discontinue heparin 1 day prior (with physician approval)", "Discontinue oral anticoagulants 7 days prior (with physician approval)"] Indications ["Suspected antiphospholipid syndrome (APS)", "Evaluation of thrombotic risk", "Investigation of recurrent pregnancy loss"] Measurement technique Confirm with laboratory Codes LOINC: 50466-6 ICD-10: D68.62 Clinical summary This test evaluates for the presence of lupus anticoagulants, which are antiphospholipid antibodies associated with an increased risk of blood clots.
TEST-2498 Menorrhagia Screen Test This diagnostic test evaluates the coagulation cascade and platelet function to identify potential bleeding disorders contributing to heavy menstrual bleeding.	Whole Blood (Sodium Citrate)	Next day (sample received by Thursday 11 AM)	950.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Prothrombin Time (PT)", "Activated Partial Thromboplastin Time (aPTT)", "Fibrinogen Levels", "Platelet Function Screening"] Parameters [{"name": "Prothrombin Time (PT)", "reference_range": null}, {"name": "Activated Partial Thromboplastin Time (aPTT)", "reference_range": null}, {"name": "Fibrinogen", "reference_range": null}, {"name": "Platelet Function Screening", "reference_range": null}] Preparation ["Overnight fasting (8–12 hours) is preferred.", "Discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling, only with prior consent from your treating physician.", "A duly filled Coagulation Requisition Form (Form 15) is mandatory."] Indications ["Evaluation of heavy menstrual bleeding (menorrhagia)", "Suspected underlying bleeding disorder", "Screening for von Willebrand disease"] Measurement technique Confirm with laboratory Codes LOINC: 34579-9 ICD-10: N92.0 Clinical summary This diagnostic test evaluates the coagulation cascade and platelet function to identify potential bleeding disorders contributing to heavy menstrual bleeding.
TEST-2553 Minimal Residual Disease (MRD) Analysis for B-Cell Acute Lymphoblastic Leukemia (B-ALL) Test This test quantifies the level of residual leukemia cells in bone marrow after initial treatment.	Bone Marrow Aspirate	Next working day (sample received by 9 AM)	1,900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Leukemic cell count", "Immunophenotype"] Parameters [{"name": "Sensitivity (Limit of Detection)", "reference_range": "0.01% (10⁻⁴) with 8–10 color panels"}] Preparation ["Provide prior immunophenotype reports", "Provide complete clinical history"] Indications ["Post-induction surveillance for B-ALL", "Risk stratification", "Guiding treatment intensification/de-escalation", "Informing stem cell transplant timing", "Relapse monitoring post-transplant"] Measurement technique Confirm with laboratory Codes LOINC: 96578-2 ICD-10: C91.00 Clinical summary This test quantifies the level of residual leukemia cells in bone marrow after initial treatment.
TEST-2543 Minimal Residual Disease (MRD) Analysis for T-ALL Test This test detects and quantifies residual T-ALL cells in bone marrow and peripheral blood using flow cytometry.	Bone Marrow Aspirate (first pull) and Peripheral Blood – Sodium Heparin Tubes	3 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Residual leukemic cells", "T-cell lineage markers", "Aberrant antigen expression patterns"] Parameters [] Preparation ["Share complete clinical history", "Provide previous immunophenotype report", "Provide current medication list", "Arrange for sample collection and immediate shipment at room temperature"] Indications ["Monitoring response to induction therapy for T-ALL", "Guiding treatment de-escalation or intensification", "Predicting relapse risk"] Measurement technique Confirm with laboratory Codes LOINC: 100368-6 ICD-10: C91.00, C91.02 Clinical summary This test detects and quantifies residual T-ALL cells in bone marrow and peripheral blood using flow cytometry.
TEST-2556 Minimal Residual Disease (MRD) Monitoring for B-Cell Chronic Lymphocytic Leukemia (B-CLL) Test This test quantifies the level of residual B-CLL cells in bone marrow or peripheral blood after treatment.	Bone Marrow Aspirate (first pull, 3 mL, green top sodium heparin) & Peripheral Whole Blood (4 mL, 2 green top sodium heparin tubes) plus 2–3 unstained BMA or peripheral smears	3 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Residual B-CLL cells", "Treatment response"] Parameters [] Preparation ["Provide sample time point relative to chemotherapy cycles", "Provide most recent diagnostic immunophenotype report", "Provide complete clinical history", "Provide test request form (TRF)", "Provide exact date and time of sample collection", "Provide full details of current therapy"] Indications ["Post-treatment monitoring for B-CLL", "Assessing treatment efficacy", "Predicting relapse risk"] Measurement technique Confirm with laboratory Codes LOINC: 53421-1 ICD-10: C91.1 Clinical summary This test quantifies the level of residual B-CLL cells in bone marrow or peripheral blood after treatment.
TEST-2547 Minimal Residual Disease (MRD) Monitoring for Multiple Myeloma Test This test detects and quantifies residual myeloma cells in the bone marrow after treatment using multiparametric flow cytometry.	Bone Marrow Aspirate (first pull)	3 working days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Residual myeloma cells", "Sensitivity to therapy"] Parameters [] Preparation ["Inform physician about anti-CD38 therapy history", "Follow specific instructions from treating doctor"] Indications ["Post-treatment monitoring for multiple myeloma", "Assessing remission depth", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 73753-8 ICD-10: C90.0 Clinical summary This test detects and quantifies residual myeloma cells in the bone marrow after treatment using multiparametric flow cytometry.

Category overview

Hematology: overview

When it comes to your circulatory health, finding precise and timely answers is essential for your peace of mind and ongoing vitality. The Hematology department at DNA Labs UAE uses highly advanced flow cytometry and automated cell counters to thoroughly analyze your blood profile. From routine counts to specialized coagulation and hematology testing in the UAE, these diagnostics provide your doctor with crucial data to manage and monitor blood-related conditions effectively. Trust in one of the most reliable diagnostic labs in Dubai and the UAE to deliver fast, highly accurate results under uncompromising confidentiality standards. Ensure your circulatory wellness today. View our hematology tests, arrange a convenient home collection, or contact our medical experts to schedule your visit.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Hematology tests in Dubai & UAE

Hematology test prices

Hematology: overview

Use the test details as a conversation starter

Related Hematology categories